{
  "ptid_time": "127_S_5218_2013-06-24",
  "img_path": "/data/qiuhui/data/adni/images/127_S_5218/2013-06-24/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 28,189 mm³, 23.7% below the reference mean. With a Z-score of -0.64 (26.1th percentile), this represents normal volume ; hippocampal volume measures 7,625 mm³, 17.4% above the reference mean. With a Z-score of 1.39 (91.8th percentile), this represents mild enlargement; whole brain volume measures 930,124 mm³, 0.2% above the reference mean. With a Z-score of 0.03 (51.0th percentile), this represents normal volume . ",
  "text_data": "Age is 82.5 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Gastrointestinal; Hematopoietic-Lymphatic; Renal-Genitourinary; Allergies or Drug Sensitivities; Malignancy; Major Surgical Procedures. MMSE: 27.0. MoCA: 19.0. Logical Memory: 9.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.95 SUVR (mild reduced); Total tau: 466.70 pg/mL (significant elevated); Phosphorylated tau: 29.58 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume is mildly enlarged, which is unusual for Alzheimer's but could suggest compensatory mechanisms or a different pathology. The MMSE is normal (27/30), but the MoCA (19/30) suggests cognitive impairment, possibly due to executive dysfunction. Elevated T-tau and P-tau with mildly reduced AV45 (amyloid PET) may indicate tauopathy rather than typical Alzheimer's pathology.  \n\n**Diagnosis:** **MCI** (given the MoCA impairment despite normal MMSE, with biomarker abnormalities but no clear dementia-level functional decline).  \n\n**Confidence:** **Medium** (discrepancy between hippocampal volume and tau biomarkers complicates the diagnosis; further clinical correlation needed).",
  "timestamp": "2025-07-26T13:28:31.530798"
}